Related Experiment Video
Updated: Aug 7, 2026

Tracking Dynamics of Muscle Engraftment in Small Animals by In Vivo Fluorescent Imaging
Published on: September 21, 2009
Bacillus Calmette-Guérin vaccine-related complications in children in Oman
Badria Al Waili1, Nasra Al Mufarajii1, Samiyah Al Hashmi1
1From the Department of Pediatrics, Royal Hospital, Muscat, Oman.
Insights
BCG vaccine complications, including severe disseminated infections, are seen in Omani children, particularly those with primary immune deficiencies. Delaying the BCG vaccine may reduce these severe outcomes in at-risk infants.
Area of Science:
- Pediatrics
- Immunology
- Vaccinology
Background:
- Bacillus Calmette-Guérin (BCG) vaccine complications occur in Omani children.
- Limited regional data exists on BCG complications, with no studies from Oman.
Purpose of the Study:
- To evaluate the spectrum of BCG vaccine-related complications in Omani children.
- To assess the immune status of children experiencing BCG complications.
Main Methods:
- Retrospective cross-sectional study conducted at a referral tertiary hospital.
- Reviewed hospital records of 226 children under 13 with BCG complications from 2006-2018.
- Analyzed clinical characteristics, treatment, immune workup, and outcomes.
Main Results:
- The most common complication was isolated BCG lymphadenitis (85%).
- BCG-related osteomyelitis (10.2%) and disseminated BCG infection (4.9%) were also observed.
- Of 11 disseminated BCG cases, 72.7% had primary immune deficiency (PID), including CGD and SCID.
Conclusions:
- The study highlights severe BCG complications in children with PID.
- Suggests delaying BCG vaccination to 6 months may prevent disseminated BCG in infants with undiagnosed PID.
- Further research is needed to support this recommendation.
Background:
Bacillus Calmette-Guérin (BCG) vaccine-related complications are frequently observed in children in Oman. There are a few regional studies on BCG complications, but none from Oman.
Objective:
Evaluate the spectrum of BCG-vaccine related complications and immune status in Omani children.
Design:
Retrospective cross-sectional study.
Setting:
Referral tertiary hospital.
Methods:
Children aged younger than 13 years old and with complications of BCG vaccination recorded from 2006-2018 were included in this study. Clinical characteristics, treatment, immune workup and outcome were reviewed from hospital records.
Main Outcome Measures:
Different BCG vaccine-related complications categorized by the site of involvement.
Sample Size:
226.
Results:
Of the 226 children had BCG-vaccine related complications, 99% received BCG vaccine immediately after birth. The median age of presentation was 4 months. The most common complication was isolated BCG lymphadenitis (85%, n=192), followed by BCG-related osteomyelitis (10.2%, n=23) and disseminated BCG infection (4.9%, n=11). The median age of presentation of disseminated BCG was 5 months, with different organs involved. Out of 11 children with disseminated BCG infection, 72.7% (n=8) had primary immune deficiency (PID), including chronic granulomatous disease (CGD, n=5), severe combined immunodeficiency (SCID) (n=2); 1 patient had Mendelian susceptibility to mycobacterial disease (IFNGR2 deficiency); 2 patients with PID not yet identified and the 1 with a non-specific PID had blood or saliva samples sent for whole-exome sequencing.
Conclusion:
Because of the spectrum of BCG vaccine-related complications, including the most severe in children with PID, we suggest that delaying the BCG vaccine from birth to 6 months may prevent disseminated BCG diseases and their complications in children with PID because any PID will have been identified before 6 months. Further studies are needed to guide this recommendation.
Limitations:
Single center-based study that may not provide a full overview of all BCG vaccine-related complications in Oman. Unavailability of details of some microbiological results and an inability to determine the detailed management for all patients.
Conflict Of Interest:
None.
Related Concept Videos
Rocky Mountain Spotted Fever
Bacterial Meningitis
Botulism
Smallpox
Poliomyelitis
Bacterial Meningitis I: Introduction

